January 2021 Bulletin: Hemorrhage Associated with Ophthalmic Procedures
| January 7, 2021
Dear Policyholders, OMIC claims data indicates that ophthalmologists who do not properly screen patients for bleeding risks and manage hemorrhage when it occurs often face malpractice lawsuits. “Hemorrhage associated with ophthalmic procedures” presents a case study, and detailed discussions of how to screen patients who may be at increased risk for hemorrhage, monitor for signs and symptoms of hemorrhage, and begin to manage an orbital compartment syndrome. OMIC Board Member Dr. Ronald Pelton co-authored the article and shared his anticoagulant forms. You may access the recommendations, anticoagulant list, anticoagulant form for patients, and anticoagulant consent form at https://www.omic.com/hemorrhage-associated-with-ophthalmic-procedures/. Sincerely, Anne M. Menke, RN, PhD CONFIDENTIALITY NOTICE: This correspondence is intended only for the person or entity to which it is addressed and may contain information that is privileged, confidential or otherwise protected from disclosure. Dissemination, distribution or copying of this e-mail or the information herein by anyone other than the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, is prohibited. If you have received this e-mail in error, please notify us at riskmanagement@omic.com and destroy the original message and all copies. |
February 2021 Bulletin: COVID-19 Vaccinations
Some policyholders have expressed interest in administering COVID-19 vaccines. Vaccination services are complex, especially for physicians who do not customarily vaccinate patients. The COVID-19 vaccine landscape is also dynamic: different vaccines, different dosing schedules, and varying availability of vaccines add to the challenge of providing this service.
In response, OMIC has created a resource outlining medical professional liability risks associated with offering the COVID-19 vaccine and recommendations to mitigate those risks https://www.omic.com/covid-19-vaccine-risk-management-considerations-and-consent/. The resource also includes a sample patient screening and vaccination consent form.
If you have questions about these risk management resources, contact us for confidential risk management advice by emailing us at riskmanagement@omic.com.
OMIC is extending coverage to its insureds for the administration of COVID19 vaccinations. Questions about coverage should be directed to OMIC’s Underwriting Department at (800) 562-6642, ext. 1, or omic@omic.com.
Thank you,
Linda D. Harrison, PhD
Vice President, OMIC Risk Management
